Recent changes

Jump to navigation Jump to search

Track the most recent changes to the wiki on this page.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 13:56, 23 April 2024
   
 
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

23 April 2024

 m   09:01  Non-degenerate nucleotides per response element‎ diffhist +974‎ Marshallsumter talk contribs (→‎Tabulation of counts)

22 April 2024

  m   20:10  Non-degenerate nucleotides per response element‎‎ 2 changes history +204‎ [Marshallsumter‎ (2×)]
 m   
20:10 (cur | prev) +153‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
09:11 (cur | prev) +51‎ Marshallsumter talk contribs (→‎Tabulation of counts)
     18:44  (Upload log)‎ [Alara E. Dagsali‎ (2×)]
     
18:44 Alara E. Dagsali talk contribs uploaded File:D2f97c72-bbfb-426e-b742-6e25234ba1ff 2.jpg ‎
     
18:43 Alara E. Dagsali talk contribs uploaded File:Ae8d4ea7-c895-403b-a435-56dc4996a3b0.JPG ‎

21 April 2024

  m   22:07  Non-degenerate nucleotides per response element‎‎ 4 changes history +3,558‎ [Marshallsumter‎ (4×)]
 m   
22:07 (cur | prev) +11‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
21:47 (cur | prev) +817‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
08:02 (cur | prev) +405‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
03:31 (cur | prev) +2,325‎ Marshallsumter talk contribs (→‎Tabulation of counts)
N    04:03  BRENZAVVY- bexagliflozin‎‎ 2 changes history +12,281‎ [Kosar Doraghi‎ (2×)]
     
04:03 (cur | prev) +198‎ Kosar Doraghi talk contribs
N    
03:47 (cur | prev) +12,083‎ Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=BRENZAVVY- bexagliflozin |aOrAn=a |drugClass=sodium-glucose co-transporter 2 (SGLT2) inhibitor |indicationType=treatment |indication=glycemic control in adults with type 2 diabetes mellitus |hasBlackBoxWarning=Yes |adverseReactions=female genital mycotic infections, urinary tract infection and increased urination |blackBoxWarningTitle=Warnings |blackBoxWarningBody=*Not re...")
     03:48  (Upload log)‎ [Kosar Doraghi‎ (4×)]
     
03:48 Kosar Doraghi talk contribs uploaded File:IMG 1052.jpeg ‎
     
03:43 Kosar Doraghi talk contribs uploaded File:IMG 1050.jpeg ‎
     
03:40 Kosar Doraghi talk contribs uploaded File:IMG 1051.jpeg ‎
     
03:34 Kosar Doraghi talk contribs uploaded File:IMG 1049.jpeg ‎

20 April 2024

      23:46  Cryptogenic cirrhosis‎‎ 16 changes history +12,312‎ [Imam Ali Shah‎ (16×)]
     
23:46 (cur | prev) +237‎ Imam Ali Shah talk contribs (→‎Prognosis) Tag: Visual edit
     
23:22 (cur | prev) −5,825‎ Imam Ali Shah talk contribs Tags: Manual revert Visual edit: Switched
     
23:22 (cur | prev) +5,825‎ Imam Ali Shah talk contribs (→‎Historical Perspective)
 m   
23:21 (cur | prev) +1‎ Imam Ali Shah talk contribs Tag: Visual edit
 m   
23:16 (cur | prev) +42‎ Imam Ali Shah talk contribs Tag: Visual edit
     
23:09 (cur | prev) +9,232‎ Imam Ali Shah talk contribs Tag: Visual edit
     
20:44 (cur | prev) −3,049‎ Imam Ali Shah talk contribs (Created a new landing page.) Tag: Visual edit
     
17:19 (cur | prev) −15‎ Imam Ali Shah talk contribs (→‎Overview) Tag: Visual edit
     
17:18 (cur | prev) +656‎ Imam Ali Shah talk contribs Tag: Visual edit: Switched
     
16:15 (cur | prev) −19‎ Imam Ali Shah talk contribs Tag: Visual edit
     
15:57 (cur | prev) +5,227‎ Imam Ali Shah talk contribs (Removed redirect to Cirrhosis) Tag: Removed redirect
 m   
15:54 (cur | prev) −43‎ Imam Ali Shah talk contribs (Changed redirect target from Https://www.wikidoc.org/index.php/Cirrhosis overview to Cirrhosis) Tags: Redirect target changed Visual edit
 m   
15:54 (cur | prev) +41‎ Imam Ali Shah talk contribs (Redirected page to Https://www.wikidoc.org/index.php/Cirrhosis overview) Tags: New redirect Visual edit
     
15:53 (cur | prev) +5‎ Imam Ali Shah talk contribs Tag: Visual edit
     
15:52 (cur | prev) −2,966‎ Imam Ali Shah talk contribs (Replaced content with "#redirect: Cirrhosis") Tag: Replaced
     
15:48 (cur | prev) +2,963‎ Imam Ali Shah talk contribs (Removed redirect to Cirrhosis) Tag: Removed redirect
     23:33  User:Imam Ali Shah‎‎ 6 changes history 0‎ [Imam Ali Shah‎ (6×)]
     
23:33 (cur | prev) −184‎ Imam Ali Shah talk contribs (→‎adada) Tag: Manual revert
     
23:33 (cur | prev) +184‎ Imam Ali Shah talk contribs Tag: Visual edit: Switched
     
23:31 (cur | prev) −964‎ Imam Ali Shah talk contribs (→‎jahdijahjdh) Tag: Manual revert
     
23:31 (cur | prev) +964‎ Imam Ali Shah talk contribs (→‎Communication Languages)
     
23:26 (cur | prev) −5,843‎ Imam Ali Shah talk contribs Tags: Manual revert Visual edit: Switched
     
23:24 (cur | prev) +5,843‎ Imam Ali Shah talk contribs
 m   20:03  Non-degenerate nucleotides per response element‎‎ 2 changes history +255‎ [Marshallsumter‎ (2×)]
 m   
20:03 (cur | prev) +51‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
08:14 (cur | prev) +204‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   17:23  H box gene transcriptions‎ diffhist 0‎ Marshallsumter talk contribs (→‎H box (Mitchell) consensus sequences)
 N    16:19  Template:IAS‎‎ 3 changes history +75‎ [Imam Ali Shah‎ (3×)]
     
16:19 (cur | prev) −33‎ Imam Ali Shah talk contribs
     
16:11 (cur | prev) +19‎ Imam Ali Shah talk contribs
N    
16:05 (cur | prev) +89‎ Imam Ali Shah talk contribs (Created page with "Associate Editor-In-Chief: Imam Ali Shah, MBBS; Chandka Medical College, Larkana Pakistan")
     03:21  User:Edzelco‎ diffhist +31‎ Edzelco talk contribs (→‎Pages Authored/Co-authored/Collaborated)
     03:20  Cipaglucosidase alfa-atga‎ diffhist +38,269‎ Edzelco talk contribs

19 April 2024

  m   21:06  Non-degenerate nucleotides per response element‎‎ 4 changes history −3,707‎ [Marshallsumter‎ (4×)]
 m   
21:06 (cur | prev) +757‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
19:50 (cur | prev) −5,407‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
07:50 (cur | prev) +779‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
01:58 (cur | prev) +164‎ Marshallsumter talk contribs (→‎Tabulation of counts)
     20:03  Template:KDRG‎‎ 2 changes history +60‎ [Kosar Doraghi‎ (2×)]
     
20:03 (cur | prev) +129‎ Kosar Doraghi talk contribs
     
19:53 (cur | prev) −69‎ Kosar Doraghi talk contribs
N    16:30  Sparsentan‎ diffhist +8,644‎ Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi[mailto:k.doraghi@yahoo.com] |genericName=sparsentan |aOrAn=an |drugClass=endothelin and angiotensin II receptor antagonist |indicationType=treatment |indication=proteinuria(reduce) in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/g |hasBlackBoxWarning=Yes |adverseReactions=Hepatotoxicity, Embryo-Fetal Tox...")
      16:24  (Upload log)‎ [Kosar Doraghi‎ (4×)]
     
16:24 Kosar Doraghi talk contribs uploaded File:IMG 1046.jpeg ‎
     
16:14 Kosar Doraghi talk contribs uploaded File:IMG 1045.jpeg ‎
     
16:11 Kosar Doraghi talk contribs uploaded File:IMG 1047.jpeg ‎
     
16:05 Kosar Doraghi talk contribs uploaded File:IMG 1044.jpeg ‎
     16:17  Somatic symptom disorder‎ diffhist +485‎ Badgettrg talk contribs (→‎Treatment)

18 April 2024

  m   22:49  Non-degenerate nucleotides per response element‎‎ 4 changes history +2,760‎ [Marshallsumter‎ (4×)]
 m   
22:49 (cur | prev) +564‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
20:37 (cur | prev) +1,206‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
08:39 (cur | prev) +727‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
04:35 (cur | prev) +263‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   18:29  Xenobiotic response element gene transcriptions‎‎ 2 changes history +93‎ [Marshallsumter‎ (2×)]
 m   
18:29 (cur | prev) +29‎ Marshallsumter talk contribs (→‎QRDRE analysis and results)
 m   
18:27 (cur | prev) +64‎ Marshallsumter talk contribs (→‎QRDRE analysis and results)
     12:48  User:Edzelco‎ diffhist +96‎ Edzelco talk contribs (→‎Pages Authored/Co-authored/Collaborated)
      12:45  Momelotinib‎‎ 2 changes history +34,070‎ [Edzelco‎ (2×)]
     
12:45 (cur | prev) −220‎ Edzelco talk contribs
     
12:44 (cur | prev) +34,290‎ Edzelco talk contribs
     12:12  Motixafortide‎ diffhist +26,053‎ Edzelco talk contribs
     11:49  Pozelimab-bbfg‎ diffhist +2,390‎ Edzelco talk contribs
     11:42  Palovarotene‎ diffhist +39,181‎ Edzelco talk contribs
     11:16  Elranatamab-bcmm‎ diffhist +32,847‎ Edzelco talk contribs
     06:18  Endocarditis overview‎ diffhist +2,588‎ Kosar Doraghi talk contribs

17 April 2024

 N    20:47  SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY‎‎ 3 changes history +364‎ [Hafiza Amna Qadeer‎ (3×)]
     
20:47 (cur | prev) −13‎ Hafiza Amna Qadeer talk contribs (minor edit) Tag: Visual edit
     
20:46 (cur | prev) +377‎ Hafiza Amna Qadeer talk contribs (new page minor edit) Tag: Visual edit
N    
19:33 (cur | prev) 0‎ Hafiza Amna Qadeer talk contribs (Created blank page)
 m   18:11  Non-degenerate nucleotides per response element‎‎ 2 changes history +601‎ [Marshallsumter‎ (2×)]
 m   
18:11 (cur | prev) +438‎ Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
06:52 (cur | prev) +163‎ Marshallsumter talk contribs (→‎Tabulation of counts)
N    08:08  Elranatamab-bcmm‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:08  Palovarotene‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:08  Pozelimab-bbfg‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:07  Motixafortide‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:07  Momelotinib‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:06  Cipaglucosidase alfa-atga‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:05  Etrasimod‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:05  Zilucoplan‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:04  Bimekizumab‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:04  Vamorolone‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:04  Mirikizumab-mrkz‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
N    08:03  Toripalimab-tpzi‎ diffhist +53‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
      08:02  User:Edzelco‎‎ 5 changes history +99‎ [Edzelco‎ (5×)]
     
08:02 (cur | prev) +18‎ Edzelco talk contribs (→‎Pages Authored/Co-authored/Collaborated)
     
07:53 (cur | prev) +26‎ Edzelco talk contribs (→‎Pages Authored/Co-authored/Collaborated)
     
07:44 (cur | prev) 0‎ Edzelco talk contribs (→‎Pages Authored/Co-authored/Collaborated)
     
07:44 (cur | prev) +36‎ Edzelco talk contribs (→‎Pages Authored/Co-authored/Collaborated)
     
07:43 (cur | prev) +19‎ Edzelco talk contribs (→‎Pages Authored/Co-authored/Collaborated)
N    08:02  Fruquintinib‎ diffhist +25,648‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=fruquintinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild‑type and medically appropriate, an anti-EGFR therapy |fdaLIADAdult=Recommended Dosage The recommended dose of F...")
 N    07:53  Taurolidine, heparin‎‎ 2 changes history +9,993‎ [Edzelco‎ (2×)]
     
07:53 (cur | prev) 0‎ Edzelco talk contribs
N    
07:52 (cur | prev) +9,993‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{Edzelco}} |genericName=taurolidine, heparin |aOrAn=a |drugClass=combination of taurolidine, a thiadiazinane antimicrobial, and heparin, an anti-coagulant |indicationType=prevention |indication=atheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients...")
N    07:43  Repotrectinib‎ diffhist +32,783‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=repotrectinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) |contraindications=None |warnings=5.1 Central Nervous System Adverse Reactions AUGTYRO can cause central nervous system adverse reactions. Among the 351 patients who received AUGTYRO in Study TRIDENT-1, a broad spectru...")
 N    07:34  Efbemalenograstim alfa-vuxw‎‎ 3 changes history +20,126‎ [Edzelco‎ (3×)]
     
07:34 (cur | prev) 0‎ Edzelco talk contribs
     
07:33 (cur | prev) +51‎ Edzelco talk contribs
N    
07:32 (cur | prev) +20,075‎ Edzelco talk contribs (Created page with "{{DrugProjectFormSinglePage |genericName=efbemalenograstim alfa-vuxw |aOrAn=a |drugClass=leukocyte growth factor |indicationType=prevention |indication=incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia |fdaLIADAdult=Recommended Dose: 20 mg administered subcutaneously once per chemotherapy cycle....")
     04:20  Endocarditis overview‎ diffhist +9,001‎ Kosar Doraghi talk contribs

16 April 2024

 m   17:29  Non-degenerate nucleotides per response element‎ diffhist +201‎ Marshallsumter talk contribs (→‎Tabulation of counts)
      15:06  Trismus‎‎ 2 changes history +223‎ [M. Arsalan Bashir‎ (2×)]
     
15:06 (cur | prev) 0‎ M. Arsalan Bashir talk contribs (→‎Treatment)
     
15:00 (cur | prev) +223‎ M. Arsalan Bashir talk contribs
Retrieved from "https://www.wikidoc.org/index.php/Special:RecentChanges"